hrcak mascot   Srce   HID

Pregledni rad

THE ROLE OF IMMUNOTHERAPY IN THE PREVENTION OF ALLERGIC DISEASES

LIBORIJA LUGOVIĆ-MIHIĆ ; Department of Dermatovenereology, Sestre milosrdnice University Clinical Center, Zagreb, Croatia
TOMISLAV DUVANČIĆ ; Department of Dermatovenereology, Sestre milosrdnice University Clinical Center, Zagreb, Croatia

Puni tekst: hrvatski, pdf (170 KB) str. 195-201 preuzimanja: 398* citiraj
APA 6th Edition
LUGOVIĆ-MIHIĆ, L. i DUVANČIĆ, T. (2011). ULOGA IMUNOTERAPIJE U PREVENCIJI ALERGIJSKIH BOLESTI. Acta medica Croatica, 65 (2), 195-201. Preuzeto s https://hrcak.srce.hr/87899
MLA 8th Edition
LUGOVIĆ-MIHIĆ, LIBORIJA i TOMISLAV DUVANČIĆ. "ULOGA IMUNOTERAPIJE U PREVENCIJI ALERGIJSKIH BOLESTI." Acta medica Croatica, vol. 65, br. 2, 2011, str. 195-201. https://hrcak.srce.hr/87899. Citirano 16.12.2019.
Chicago 17th Edition
LUGOVIĆ-MIHIĆ, LIBORIJA i TOMISLAV DUVANČIĆ. "ULOGA IMUNOTERAPIJE U PREVENCIJI ALERGIJSKIH BOLESTI." Acta medica Croatica 65, br. 2 (2011): 195-201. https://hrcak.srce.hr/87899
Harvard
LUGOVIĆ-MIHIĆ, L., i DUVANČIĆ, T. (2011). 'ULOGA IMUNOTERAPIJE U PREVENCIJI ALERGIJSKIH BOLESTI', Acta medica Croatica, 65(2), str. 195-201. Preuzeto s: https://hrcak.srce.hr/87899 (Datum pristupa: 16.12.2019.)
Vancouver
LUGOVIĆ-MIHIĆ L, DUVANČIĆ T. ULOGA IMUNOTERAPIJE U PREVENCIJI ALERGIJSKIH BOLESTI. Acta medica Croatica [Internet]. 2011 [pristupljeno 16.12.2019.];65(2):195-201. Dostupno na: https://hrcak.srce.hr/87899
IEEE
L. LUGOVIĆ-MIHIĆ i T. DUVANČIĆ, "ULOGA IMUNOTERAPIJE U PREVENCIJI ALERGIJSKIH BOLESTI", Acta medica Croatica, vol.65, br. 2, str. 195-201, 2011. [Online]. Dostupno na: https://hrcak.srce.hr/87899. [Citirano: 16.12.2019.]

Sažetak
Immunotherapy through repeated administration of allergens and augmentation of doses (hyposensibilization) with the purpose of decreasing the severity of type I allergic reactions or even its complete elimination is known already for a longer period of time. This type of therapy is especially beneficial in allergies to Hymenoptera venom, allergic rhinoconjunctivitis, allergic asthma and is implemented in patients with previously proven allergy to appropriate allergens (insects, pollen, house dust mite, pet dander and other). The most common form of therapy is subcutaneous immunotherapy which includes a series of injections containing specific allergens (allergy vaccines) with increasingly larger doses administered subcutaneously during a period of 3-5 years. There are also other forms of immunotherapy (for instance sublingual immunotherapy) although these are less effective. Repetition of the hyposensibilization procedure leads to further reduction in severity of allergy disease in the majority of patients. The efficacy of immunotherapy is also proven by a lower risk of allergic rhinitis patients developing asthma as well as by prevention of new sensibilizations.

Ključne riječi
immunotherapy; hyposensibilization; allergy

Hrčak ID: 87899

URI
https://hrcak.srce.hr/87899

[hrvatski]

Posjeta: 678 *